Suppr超能文献

甲硝唑制剂(Vagimid)的生物利用度。

Bioavailability of metronidazole formulations (Vagimid).

作者信息

Siegmund W, Zschiesche M, Franke G, Wilke A

机构信息

Medical Faculty, Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University, Greifswald.

出版信息

Pharmazie. 1992 Jul;47(7):522-5.

PMID:1518897
Abstract

The bioavailability of metronidazole (0.5 g) from Vagimid tablets and dragées were compared with tablets of a reference formulation in 12 male healthy volunteers (age 20-32 years, body weight 61-77 kg). Metronidazole and its two main oxidized metabolites in serum were determined quantitatively with an hplc method. Metronidazole from Vagimid tablets was absorbed more rapidly than from the reference but at the same extent of absorption. The pharmacokinetic profile of Vagimid dragées was similar to the behaviour of the reference but AUC of dragées was slightly but significantly lower. All elimination parameters of metronidazole as well as the formation of the two metabolites were not different after administration of the oral formulations.

摘要

在12名健康男性志愿者(年龄20 - 32岁,体重61 - 77千克)中,比较了Vagimid片和糖衣丸中甲硝唑(0.5克)与参比制剂片的生物利用度。采用高效液相色谱法对血清中的甲硝唑及其两种主要氧化代谢物进行定量测定。Vagimid片中的甲硝唑吸收速度比参比制剂快,但吸收程度相同。Vagimid糖衣丸的药代动力学特征与参比制剂相似,但糖衣丸的AUC略低但有显著差异。口服制剂给药后,甲硝唑的所有消除参数以及两种代谢物的形成均无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验